| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 137,737 | 118,179 | 108,910 | 148,013 | | Cost of Revenue | 89,777 | 71,601 | 65,507 | 95,716 | | | Gross Profit | 47,960 | 46,578 | 43,403 | 52,297 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 24,140 | 25,092 | 25,200 | 27,006 | | Non Recurring | 190 | 11 | 555 | 59,887 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 23,630 | 21,475 | 17,648 | (34,596) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (688) | (1,278) | 488 | 1,267 | | Earnings Before Interest And Taxes | (20,041) | 20,197 | 18,136 | (33,329) | | Interest Expense | (28,769) | 14,622 | 14,147 | 14,117 | | Income Before Tax | 8,728 | 5,575 | 3,989 | (47,446) | | Income Tax Expense | 2,267 | 1,365 | 1,028 | (3,085) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,461 | 4,210 | 2,961 | (44,361) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,461 | 4,210 | 2,961 | (44,361) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,461 | $4,210 | $2,961 | ($44,361) |
|
0.11% Nasdaq 0.00%
Income Statement
